Is Crown Resorts Ltd a buy after its 16% fall?

Long-term investors should be excited by growth prospects.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What?

Shares of Crown Resorts Ltd (ASX: CWN) have fallen by 16% over the last 16 weeks on fears that gaming growth in Macau and Australia is slowing. The fall in Crown's share price can be explained by the 25% drop in the share price of Macau-based casino group Melco Crown, which Crown holds a 33% stake in.

So What?

Fundamentally, little has changed for Crown. There have been some concerns surrounding growth in global gaming markets for the past 18 months as VIP revenue in Australia and Asia has grown slower than some forecasters had estimated.

Investors should keep in mind that Melco Crown still managed to grow first quarter revenue by 19% and earnings by 31%. Unless this growth drops off significantly, which I consider unlikely over the medium term with so many growth catalysts in the pipeline, the current price appears attractive for a long-term entry into the stock.

Now What?

The next four or five years will be a period of growth and investment for Crown and Melco Crown. Crown has new casinos to come in Sydney, Sri Lanka, and potentially Japan and the USA, as well as upgrades to existing Australian facilities.

In my view, the main risk for Crown is a poor investment decision when chasing growth. James Packer is in charge of the company and has made some exceptional investments during his time, however with Crown active on so many fronts, there is the chance that one of the future growth projects underperforms and becomes a drag on earnings.

Having said that, Crown's share price is now back to where it was in September 2013 and is trading on an estimated forward price-to-earnings ratio of 16.5. This compares with an average of around 17.5 over the past six years, however with earnings per share expected to rise by 15% in each of the next two years and further accelerate in the years after that, the valuation may well be justified.

Motley Fool contributor Andrew Mudie does not own shares in any companies mentioned. You can find Andrew on Twitter @andrewmudie

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »